Web Analytics Made Easy -

Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch

2 months ago 45

Company Close Updates

Published: March 25, 2021 astatine 5:14 p.m. ET

Company Logo

Terrence Horan

Shares of Novavax Inc. NVAX, -10.99% took a -11% dive 10.99% to $178.23 Thursday, connected what proved to beryllium an all-around large trading league for the banal market, with the NASDAQ Composite Index COMP, +0.12% rising 0.12% to 12,977.68 and the Dow Jones Industrial Average DJIA, +0.62% rising 0.62% to 32,619.48. This was the stock's 3rd consecutive time of losses. Novavax Inc. closed $153.45 abbreviated of its 52-week precocious ($331.68), which the institution achieved connected February 9th.

The banal underperformed erstwhile compared to immoderate of its competitors Thursday, arsenic Replimune Group Inc. REPL, +5.06% roseate 5.06% to $31.75, VBI Vaccines Inc. VBIV, +5.73% roseate 5.73% to $3.23, and AnaptysBio Inc. ANAB, +6.51% roseate 6.51% to $21.12. Trading measurement (7.4 M) eclipsed its 50-day mean measurement of 4.6 M.

Editor's Note: This communicative was auto-generated by Automated Insights, an automation exertion provider, utilizing information from Dow Jones and FactSet. See our marketplace information presumption of use.

Read Entire Article